Your search matched 1 results
Orphan Medicines: Averting Price Debacles And Winning Payer Support | In The Media
In this collaborative piece, Meg Alexander, Managing Director of our Reputation & Risk Management practice and Susan Suponcic, Managing Director of our Pricing and Market Access practice, highlight misalignments in perception that derail access to orphan drugs.
Already have a RSS feed reader?
